Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/13/00 → 2/28/02 |
Financiación
- Glaxo Wellcome: 2.550,00 US$
A Double-Blind, Randomized, Placebo-Controlled Surveillance Study of Asthma Event Outcomes in Subjects Receiving Either Usual Pharmacotherapy of Asthma or Usual Pharmacotherapy Plus Salmeterol 42 mcg (2 Puffs) Twice Daily
- Miller, Beth (PI)